Roivant Sciences ROIV
NASDAQ ROIV
$41.38 -0.10 (-0.25%)
As of: Sep 9, 2026 · 11:15 AM EDT

Roivant Sciences (ROIV) Goodwill & Intangibles (2022 - 2024)

Roivant Sciences' (ROIV) quarterly Goodwill & Intangibles came in at $155.8 million in Q2 2024, little changed on a YoY basis from $155.3 million in Q3 2023, and little changed quarter-over-quarter from $155.2 million in Q1 2024.

Analysis

Roivant Sciences (ROIV) Goodwill & Intangibles (2022 - 2024) Analysis & Trends

Roivant Sciences (ROIV) has reported Goodwill & Intangibles for 3 consecutive years, with $155.8 million the latest figure, recorded in Q2 2024.

  • For the quarter ending Q2 2024, Goodwill & Intangibles changed 0.32% year-over-year to $155.8 million; the trailing twelve-month figure through Jun 2024 stood at $155.8 million (changed 0.32% YoY), and the FY2024 full-year result was $155.2 million, up 1.67% from the prior year.
  • Goodwill & Intangibles held at $155.8 million in Q2 2024 per ROIV's latest filing, from $155.2 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $166.5 million in Q4 2023 and bottomed at $143.2 million in Q3 2022.
  • Historically, Goodwill & Intangibles has averaged $153.2 million across 3 years, with a median of $153.1 million in 2023.
  • The sharpest annual moves came in 2023 and 2024: Goodwill & Intangibles increased 9.89% in 2023, then increased 0.32% in 2024.
  • Over 3 years, Goodwill & Intangibles stood at $151.5 million in 2022, then grew by 9.89% to $166.5 million in 2023, then retreated by 6.42% to $155.8 million in 2024.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $155.8 million, $155.2 million, and $166.5 million for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.68 Bn 197.69 Bn 7.24 Bn
2 Gilead Sciences 180.84 Bn 177.66 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.30 Bn 124.45 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.50 Bn 74.50 Bn 3.93 Bn
5 Argenx Se 61.49 Bn 56.31 Bn 1.37 Bn
6 Moderna 55.01 Bn 49.87 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.08 Bn 30.77 Bn 992.69 Mn
8 Biogen 31.35 Bn 30.06 Bn 1.96 Bn
9 Roivant Sciences 29.87 Bn 29.87 Bn 1.16 Mn
10 Insmed 27.84 Bn 26.68 Bn 358.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 155.78 Mn
Mar 31, 2024 155.17 Mn
Dec 31, 2023 166.47 Mn
Sep 30, 2023 153.05 Mn
Jun 30, 2023 155.28 Mn
Mar 31, 2023 152.63 Mn
Dec 31, 2022 151.49 Mn
Sep 30, 2022 143.21 Mn
Jun 30, 2022 145.43 Mn